11. Conclusion

In summary, we find SCE's costs associated with its participation in Phase I and Phase II of the HECA Study to be reasonable and authorize their recovery. Thus, SCE is authorized to recover up to $17 million for Phase I costs recorded or to be recorded in the HECAMA. SCE is also authorized to recover up to $13 million in costs for Phase II of the HECA Study recorded or to be recorded in the HECAMA, subject to the usual reasonableness review in a future ERRA reasonableness proceeding.

In addition, we approve SCE's Public Disclosure Plan as described in the record of this proceeding. We further find that SCE has fulfilled all the requirements placed upon this application by Resolution E-4227A.

There are no outstanding issues in this proceeding, and it should be closed.